Literature DB >> 15592195

Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris.

Allan Johansen1, Poul Flemming Høilund-Carlsen, Henrik Wulff Christensen, Peter Grupe, Annegrete Veje, Werner Vach, Torben Haghfelt.   

Abstract

BACKGROUND: Observer variability of dual-isotope myocardial perfusion imaging (MPI) with single photon emission computed tomography has rarely been investigated. The aim of our study was to evaluate the interpretive reproducibility with this technique. METHODS AND
RESULTS: We report on 507 patients with known or suspected stable angina who were studied before coronary angiography. A 1-day thallium 201/technetium 99m sestamibi rest/stress MPI protocol was used. MPI was interpreted by 2 independent observers without knowledge of clinical data, using a 20-segment scoring model. By consensus, the overall rate of abnormal MPI was 49% (59% in men and 34% in women). The interobserver agreement for the whole group (kappa = 0.85) and for men and women separately (kappa = 0.86 and 0.82, respectively) was excellent with regard to the overall diagnosis (normal, reversible, or fixed defects) as well as left anterior descending and left circumflex artery vascular territories (kappa = 0.85 and 0.82, respectively). However, in the right coronary artery territory, agreement was excellent in men (kappa = 0.83) but moderate in women (kappa = 0.57).
CONCLUSIONS: In a relatively large group of men and women with stable angina pectoris, interpretive reproducibility (overall and individual vessel diagnosis) was excellent, except in the right coronary artery territory of women, in which it was moderate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592195     DOI: 10.1016/j.nuclcard.2004.06.130

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

Authors:  L J Shaw; R Hachamovitch; D S Berman; T H Marwick; M S Lauer; G V Heller; A E Iskandrian; K L Kesler; M I Travin; H C Lewin; R C Hendel; S Borges-Neto; D D Miller
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

Review 3.  Technetium 99m sestamibi in the assessment of chronic coronary artery disease.

Authors:  D S Berman; H Kiat; K Van Train; E Garcia; J Friedman; J Maddahi
Journal:  Semin Nucl Med       Date:  1991-07       Impact factor: 4.446

4.  Interpretive reproducibility of stress Tc-99m sestamibi tomographic myocardial perfusion imaging.

Authors:  R J Golub; A W Ahlberg; J R McClellan; S D Herman; M I Travin; J F Mather; P W Aitken; J I Baron; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

5.  Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT.

Authors:  A M Amanullah; D S Berman; R Hachamovitch; H Kiat; X Kang; J D Friedman
Journal:  Am J Cardiol       Date:  1997-07-15       Impact factor: 2.778

6.  Interhospital observer agreement in interpretation of exercise myocardial Tc-99m tetrofosmin SPECT studies.

Authors:  J Candell-Riera; C Santana-Boado; B Bermejo; L Armadans; J Castell; I Casáns; J Jurado; J Magriñá; J N de la Rosa
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

7.  Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; C N Bairey; I Cohen; A Cabico; J Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

8.  Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness.

Authors:  Rory Hachamovitch; Daniel S Berman; Hosen Kiat; Ishac Cohen; John D Friedman; Leslee J Shaw
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosmin.

Authors:  R C Hendel; M A Parker; F J Wackers; P Rigo; A Lahiri; B L Zaret
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

10.  Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; X Kang; K F Van Train; H C Lewin; I Cohen; J Areeda; J D Friedman; G Germano; L J Shaw; R Hachamovitch
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

View more
  9 in total

1.  Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias.

Authors:  Allan Johansen; Poul Flemming Høilund-Carlsen; Henrik Wulff Christensen; Werner Vach; Henrik Boel Jørgensen; Annegrete Veje; Torben Haghfelt
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

2.  Angina pectoris: has the cornerstone of symptomatic coronary artery disease been moved?

Authors:  Renee C Hessian; Rob S B Beanlands
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

3.  Analysis of serial images: a challenge and an opportunity.

Authors:  Ami E Iskandrian; Ernest V Garcia; Tracy Faber
Journal:  J Nucl Cardiol       Date:  2007-10-29       Impact factor: 5.952

4.  Frontline diagnostic evaluation of patients suspected of angina by coronary computed tomography reduces downstream resource utilization when compared to conventional ischemia testing.

Authors:  Lene H Nielsen; John Markenvard; Jesper M Jensen; Hans Mickley; Kristian A Øvrehus; Bjarne L Nørgaard
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-02       Impact factor: 2.357

5.  Can preoperative myocardial perfusion scintigraphy predict changes in left ventricular perfusion and function after coronary artery bypass graft surgery?

Authors:  Rozy Eckardt; Bo Juel Kjeldsen; Allan Johansen; Peter Grupe; Torben Haghfelt; Per Thayssen; Lars Ib Andersen; Birger Hesse
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-02

6.  Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris.

Authors:  Allan Johansen; Poul Flemming Høilund-Carlsen; Henrik Wulff Christensen; Werner Vach; Mette Møldrup; Torben Haghfelt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-12       Impact factor: 9.236

7.  Significant association of female gender with lower degree of pathological 99mTc-sestamibi scintigraphy results as well as higher cardiac-related deaths free survival in elderly patients.

Authors:  Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Michael J Reinhardt; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Journal:  Med Klin (Munich)       Date:  2011-01-16

8.  High probability of disease in angina pectoris patients: is clinical estimation reliable?

Authors:  Poul F Høilund-Carlsen; Allan Johansen; Werner Vach; Henrik Wulff Christensen; Mette Møldrup; Torben Haghfelt
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

9.  The use of pre-test and post-test probability values as criteria before selecting patients to undergo coronary angiography in patients who have ischemic findings on myocardial perfusion scintigraphy.

Authors:  Nazlı Pınar Karahan Şen; Recep Bekiş; Ali Ceylan; Erkan Derebek
Journal:  Anatol J Cardiol       Date:  2015-11-30       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.